Rippon Ubhi

Rippon brings close to 20 years of senior commercial leadership experience in multiple countries including Japan, the UK, the USA; and more broadly at a Global level covering China, Russia, Brazil, to name a few. Rippon joined Sanofi in late 2022 after 18 years at AstraZeneca.

As the Country Lead for Sanofi in the UK & Ireland, Rippon champions Sanofi's NHS and Government engagement to bring the miracles of science to people with serious and life-threatening diseases and to better support NHS teams. She has taken an industry leading role in driving improvements to the decision-making process around the differential value of medicines across multiple indications.

Rippon is leading teams across Sanofi to pioneer innovation, business growth and improved patient outcomes through the transformative potential of artificial intelligence. This includes accelerating patient diagnosis, enhancing employee productivity and improving decision making to overcome health challenges and help transform the field of medicine with AI.

She was a strong advocate for Women’s leadership in Japan and the US at AstraZeneca. At Sanofi, she continues to play a leading role in driving forward Sanofi's commitments and initiatives in diversity, equity and inclusion. She defines herself as “I’mPossible”, believing very strongly that anyone across the globe can turn the impossible into the possible, no matter their gender nor their ethnicity.

Rippon is keen to bring her track record of challenging the status quo, pushing boundaries to make increased access and uptake of innovative medicines a reality in the UK and welcomes the opportunity to continue her work on this with the ABPI.